Found: 2
Select item for more details and to access through your institution.
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.
- Published in:
- Molecular Cancer, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12943-021-01437-0
- By:
- Publication type:
- Article
Poly-ε-Caprolactone/Gelatin Hybrid Electrospun Composite Nanofibrous Mats Containing Ultrasound Assisted Herbal Extract: Antimicrobial and Cell Proliferation Study.
- Published in:
- Nanomaterials (2079-4991), 2019, v. 9, n. 3, p. 462, doi. 10.3390/nano9030462
- By:
- Publication type:
- Article